Compare INM & RGTIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INM | RGTIW |
|---|---|---|
| Founded | 1981 | 2013 |
| Country | Canada | United States |
| Employees | N/A | 164 |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7M | N/A |
| IPO Year | 2020 | N/A |
| Metric | INM | RGTIW |
|---|---|---|
| Price | $0.68 | $5.55 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 81.2K | ★ 94.2K |
| Earning Date | 05-11-2026 | 03-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $4,942,633.00 | ★ $11,892,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 7.50 | N/A |
| 52 Week Low | $0.58 | $2.48 |
| 52 Week High | $7.98 | $46.78 |
| Indicator | INM | RGTIW |
|---|---|---|
| Relative Strength Index (RSI) | 39.99 | 41.21 |
| Support Level | N/A | $5.07 |
| Resistance Level | $0.94 | $6.63 |
| Average True Range (ATR) | 0.07 | 0.74 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 27.76 | 36.50 |
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.
Rigetti Computing Inc builds quantum computers and the superconducting quantum processors that power them. The Company sells 9-qubit to 108-qubit quantum computing systems under the Novera and Cepheus trade names. Through the Rigetti Quantum Cloud Services (QCS) platform, the Company's machines can be integrated into any public, private or hybrid cloud. The Company also operates in Fremont, California; London, United Kingdom; Adelaide, Australia; British Columbia, Canada and Mumbai, India. The Company's revenue is derived from operations in the United States and the United Kingdom.